Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • Opinnäytteet - ylempi korkeakoulututkinto
  • Näytä viite
  •   Etusivu
  • Trepo
  • Opinnäytteet - ylempi korkeakoulututkinto
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Testing a novel method for protein - assembly based vaccine construction

Badal, Nasir Uddin (2019)

 
Avaa tiedosto
NasirBadal.pdf (1.359Mt)
Lataukset: 



Badal, Nasir Uddin
2019

Bioteknologian ja biolääketieteen tekniikan maisteriohjelma - Master's Programme in Biotechnology and Biomedical Engineering
Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Hyväksymispäivämäärä
2019-06-28
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202202172006
Tiivistelmä
Vaccination is thought to be the most effective and versatile component against infectious diseases. Emerging infectious diseases and limited effectiveness of currently available influenza vaccine can cause a serious public health threat to people worldwide. Millions of people are affected in yearly influenza outbreaks and more than 250,000 lives are lost annually. This study aimed to create a universal influenza vaccine prototype that will be cost effective, easy to produce, would provide long-term immunity and effectiveness against multiple strains of influenza and would be highly immunogenic. This kind of vaccine can be possibly formed by conjugating conserved M2e antigen and Norovirus-like particle (NoV-VLP) using two peptide tags (Spy-Tag and K-Tag) and Spyligase protein.
The extracellular domain of influenza A virus matrix protein-2 (M2e) was aimed to use as target antigen. M2e antigen was fused with a peptide tag (K-Tag) for the formation of isopeptide bond with another peptide tag (Spy-Tag) with the help of Spyligase. Spyligase is the essential enzyme to form covalent bond between K-Tag-Spy-Tag, that was expressed in BL21 Star DE3 E. coli strain. After complete purification of Spyligase using immobilized metal affinity chromatography (IMAC) method, 86 mg/l of Spyligase protein was obtained with ˃95% purity. Spy-Tag was genetically fused with Noro VLP so that, VLP could be decorated and conjugated with K-Tagged antigen. Spy Noro VLP was expressed in Hi-5 insect cells and purified with tangential flow filtration (TFF), 30 % sucrose cushion pelleting and anion exchange chromatography. Estimated yield from this purification was 133 mg/l with ˃95% purity. WT Noro VLP was purified using the same protocol as Spy Noro VLP and yield was 3.8 mg/l with ˃95% or ˃50% purity. Hydrodynamic diameter for Spy Noro VLP was 51 nm and for >95% pure WT Noro VLP and >50% pure WT Noro VLP were 53 nm and 32 nm respectively.
Spy-Tagged Noro virus like particle, K-Tagged antigen and Spyligase were mixed together and incubated at 4ºC for 24 hours. SDS-PAGE and western blot analysis showed the isopeptide bond formation and successful conjugation of two peptide tag.
Kokoelmat
  • Opinnäytteet - ylempi korkeakoulututkinto [41685]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste